Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …

While lung cancer has been the leading cause of cancer-related deaths for many years in
the United States, incidence and mortality statistics–among other measures–vary widely …

Background Standard first-line therapy for metastatic, squamous non–small-cell lung cancer
(NSCLC) is platinum-based chemotherapy or pembrolizumab (for patients with programmed …

Lung cancer is the leading cause of cancer mortality, and early detection is key to improving
survival. However, there are no reliable blood-based tests currently available for early-stage …

Purpose This study used the Surveillance, Epidemiology, and End Results (SEER) data to
investigate the changes in incidence, treatment, and survival of lung cancer from 1973 to …

Introduction Our aim was to update global lung cancer epidemiology and describe changing
trends and disparities. Methods We presented country-specific incidence and mortality from …

Context Renal cell carcinoma (RCC) incidence rates are higher in developed countries,
where up to half of the cases are discovered incidentally. Declining mortality trends have …

Background There are several studies comparing the difference between adenocarcinoma
(AC) and squamous cell carcinoma (SqCC) of lung cancer. However, seldom studies …

Chronic obstructive pulmonary disease (COPD), the frequently fatal pathology of the
respiratory tract, accounts for half a billion cases globally. COPD manifests via chronic …

The history of lung cancer epidemiology parallels the history of modern chronic disease
epidemiology. Although an excess of lung cancer was firstly observed among miners and …